 |
|
The gut–kidney connection in advanced chronic kidney disease
Reiko Inagi
Kidney Res Clin Pract. 2015;34(4):191-193. Published online 2015 Oct 2 DOI: https://doi.org/10.1016/j.krcp.2015.08.007
|
|
Citations to this article as recorded by
 Use of antibiotics as a therapeutic approach to prevent AKI-to-CKD progression
Yu Kurata, Masaomi Nangaku
Kidney International.2023; 104(3): 418. CrossRef Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
Yanhuan Feng, Lingzhi Li, Fan Guo, Yanping Li, Yan Liang, Lin Bai, Liang Ma, Ping Fu
RSC Advances.2018; 8(70): 40232. CrossRef Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model
Eikan Mishima, Shinji Fukuda, Yoshitomi Kanemitsu, Daisuke Saigusa, Chikahisa Mukawa, Kei Asaji, Yotaro Matsumoto, Hiroki Tsukamoto, Tatsuki Tachikawa, Tomoya Tsukimi, Noriko N. Fukuda, Hsin-Jung Ho, Koichi Kikuchi, Chitose Suzuki, Fumika Nanto, Takehiro
American Journal of Physiology-Renal Physiology.2018; 315(4): F824. CrossRef Dietary Metabolites and Chronic Kidney Disease
Sho Hasegawa, Tzu-Ming Jao, Reiko Inagi
Nutrients.2017; 9(4): 358. CrossRef The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response
Wei Huang, Luping Zhou, Hengli Guo, Youhua Xu, Yong Xu
Metabolism.2017; 68: 20. CrossRef D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation
Akira Okada, Masaomi Nangaku, Tzu-Ming Jao, Hiroshi Maekawa, Yu Ishimono, Takahisa Kawakami, Reiko Inagi
Scientific Reports.2017;[Epub] CrossRef
|